Literature DB >> 17520718

Normalized left ventricular volumes and function in thalassemia major patients with normal myocardial iron.

Mark A Westwood1, Lisa J Anderson, Alicia M Maceira, Farrukh T Shah, Emma Prescott, John B Porter, Beatrix Wonke, J Malcolm Walker, Dudley J Pennell.   

Abstract

PURPOSE: To determine the reference range in thalassemia major (TM) for left ventricular (LV) function.
MATERIALS AND METHODS: We used cardiovascular magnetic resonance (CMR) to measure heart volumes and function in 81 TM patients with normal myocardial T2* measurements (T2* > 20 msec) and by inference without excess myocardial iron. Forty age- and gender-matched healthy controls were also studied.
RESULTS: Resting LV volumes and function normalized to body surface area differed significantly between TM patients and controls. The lower limit and the mean for ejection fraction (EF) were higher in TM patients (males 59 vs. 55%, mean 71% vs. 65%; females 63 vs. 59%, mean 71% vs. 67%; both P < 0.001). The upper limit and mean for end-diastolic volume index were higher in TM patients (males 152 vs. 105 mL/m(2), mean 97 vs. 84 mL/m(2); females 121 vs. 99 mL/m(2), mean 87 vs. 79 mL/m(2); both P < 0.05). In TM patients the cardiac index (P < 0.001) was increased.
CONCLUSION: At rest, TM patients with a normal myocardial T2* have different "normal" values for LV volume and function parameters compared to controls, and this has the potential to lead to a misdiagnosis of cardiomyopathy. We present new reference "normal" ranges in TM to alleviate this problem. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17520718     DOI: 10.1002/jmri.20915

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  27 in total

1.  Effects of deferasirox-deferoxamine on myocardial and liver iron in patients with severe transfusional iron overload.

Authors:  Yesim Aydinok; Antonis Kattamis; M Domenica Cappellini; Amal El-Beshlawy; Raffaella Origa; Mohsen Elalfy; Yurdanur Kilinç; Silverio Perrotta; Zeynep Karakas; Vip Viprakasit; Dany Habr; Niculae Constantinovici; Junwu Shen; John B Porter
Journal:  Blood       Date:  2015-05-01       Impact factor: 22.113

2.  Cardiovascular magnetic resonance and thalassaemia.

Authors:  J P Carpenter; D J Pennell
Journal:  Int J Cardiovasc Imaging       Date:  2008-09-02       Impact factor: 2.357

3.  Electrocardiographic consequences of cardiac iron overload in thalassemia major.

Authors:  Jon Detterich; Leila Noetzli; Fred Dorey; Yaniv Bar-Cohen; Paul Harmatz; Thomas Coates; John Wood
Journal:  Am J Hematol       Date:  2011-11-04       Impact factor: 10.047

4.  The effect of metoprolol succinate on the cardiac function of patients with thalassaemia cardiomyopathy: a double-blind randomised study.

Authors:  Javad Kojury; Abdolali Zolghadrasli; Mehran Karimi; Mohammad Ali Babaee Beighi; Soha Namazi
Journal:  Heart Asia       Date:  2014-04-17

Review 5.  Early detection of cardiac involvement in thalassemia: From bench to bedside perspective.

Authors:  Nut Koonrungsesomboon; Siriporn C Chattipakorn; Suthat Fucharoen; Nipon Chattipakorn
Journal:  World J Cardiol       Date:  2013-08-26

6.  Cardiac iron and cardiac disease in males and females with transfusion-dependent thalassemia major: a T2* magnetic resonance imaging study.

Authors:  Maria Marsella; Caterina Borgna-Pignatti; Antonella Meloni; Valeria Caldarelli; Maria Chiara Dell'Amico; Anna Spasiano; Lorella Pitrolo; Eliana Cracolici; Gianluca Valeri; Vincenzo Positano; Massimo Lombardi; Alessia Pepe
Journal:  Haematologica       Date:  2011-01-12       Impact factor: 9.941

7.  Comparison of biventricular dimensions and function between pediatric sickle-cell disease and thalassemia major patients without cardiac iron.

Authors:  Antonella Meloni; Jon Detterich; Vasili Berdoukas; Alessia Pepe; Massimo Lombardi; Thomas D Coates; John C Wood
Journal:  Am J Hematol       Date:  2013-02-06       Impact factor: 10.047

Review 8.  Estimating tissue iron burden: current status and future prospects.

Authors:  John C Wood
Journal:  Br J Haematol       Date:  2015-03-12       Impact factor: 6.998

Review 9.  Cardiac complications in thalassemia major.

Authors:  John C Wood
Journal:  Hemoglobin       Date:  2009       Impact factor: 0.849

10.  History and current impact of cardiac magnetic resonance imaging on the management of iron overload.

Authors:  John C Wood
Journal:  Circulation       Date:  2009-11-02       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.